The growing adoption of precision oncology across the United States is supporting demand for HER2 antibodies. Advanced cancer diagnostic facilities and established healthcare infrastructure are encouraging the use of targeted therapies.
Market Overview
The HER2 Antibodies Market is expected to register a CAGR of 5.1% from 2025 to 2031. The market valuation is reported as US$ XX...
